Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Cash Flows

v2.4.0.6
Consolidated Statements of Cash Flows (USD $)
 3 Months Ended
Mar. 31, 2013
Mar. 31, 2012
CASH FLOWS FROM OPERATING ACTIVITIES:    
Net loss attributable to Tecogen Inc. $ (978,540) $ (541,148)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:    
Depreciation and amortization 55,857 47,892
Provision for losses on accounts receivable (8,900) 0
Provision (recovery) for inventory reserve 0 3,800
Stock-based compensation 57,638 95,053
Changes in operating assets and liabilities    
Short-term investments (202) (1,997)
Accounts receivable (306,849) (797,309)
Inventory (49,077) (586,570)
Costs in excess of billing (354,625) 0
Due from related party 55,837 (49,958)
Prepaid expenses and other current assets 92,803 (78,806)
Increase (decrease) in:    
Accounts payable 310,898 201,889
Accrued expenses 198,618 17,731
Deferred revenue (110,511) (99,249)
Due to related party 760,535 0
Interest payable, related party 20,802 17,802
Net cash used in operating activities (255,716) (1,770,870)
CASH FLOWS FROM INVESTING ACTIVITIES:    
Purchases of property and equipment (313,002) (68,244)
Purchases of intangible assets (323,391) (19,658)
Net cash used in investing activities (636,393) (87,902)
CASH FLOWS FROM FINANCING ACTIVITIES:    
Proceeds from sale of subsidiary common stock 0 500,000
Net cash provided by financing activities 0 500,000
Net increase (decrease) in cash and cash equivalents (892,109) (1,358,772)
Cash and cash equivalents, beginning of the period 1,572,785 3,018,566
Cash and cash equivalents, end of the period 680,676 1,659,794
Non-cash investing and financing activities:    
Interest paid $ 0 $ 0